Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Piramal Pharma Solutions Appoints CCO | Contract Pharma
Promotions & Moves

Piramal Pharma Solutions Appoints CCO

Needleman responsible for driving all global business development activities

Stuart E. Needleman has been appointed chief commercial officer, Piramal Pharma Solutions (PPS). Mr. Needleman will play a key role in the growth and execution of PPS’ global pharmaceutical offerings. He will be responsible for driving all global business development activities for the services business, ranging from discovery services to commercial supply, in both drug substance and drug product.

Prior to joining the company, Mr. Needleman served as president of Laurus Synthesis, a subsidiary of Laurus Labs. Prior to Laurus, he was president and chief operating officer of Aptuit. He also held key roles at Cambrex, Oxford Asymmetry, ChiRex, Rhodia Pharma Solutions and Arch Pharmalabs.

Vivek Sharma, chief executive officer, Piramal Pharma Solutions said, “Stu is a respected senior executive in the contract services industry, having held leadership roles in business development, sales and marketing, and operations, in a distinguished career that spans nearly three decades. His track record of driving sustainable growth at attractive margins, across several leading global organizations is well acknowledged by the industry. He also has had proven experience in developing seamless solutions that integrate drug substance and drug products. We are delighted to have him on board and believe that his extensive experience, and leadership traits, will be a perfect fit with our culture, as we move forward towards the strategic vision of becoming the ‘partner-of-choice’ for firms across the globe.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters